Learn more about HPV self-collection, a step closer to eliminating cervical cancer, and its importance in early detection and prevention. Find out how this simple test can save lives.

Pfizer's reported interest in acquiring sickle cell disease specialist Global Blood Therapeutics (GBT) has been confirmed, with the $68.50-per-share deal valuing GBT at $5.4 billion.